BEAM - Beam Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

BEAM is currently covered by 9 analysts with an average price target of $46.56. This is a potential upside of $25.66 (122.78%) from yesterday's end of day stock price of $20.9.

Beam Therapeutics's activity chart (see below) currently has 160 price targets and 151 ratings on display. The stock rating distribution of BEAM is 92.86% BUY and 7.14% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 39.42% of the time, taking 78.63 days on average.

Highest price target for BEAM is $80, Lowest price target is $26, average price target is $46.56.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 11-Nov-2026. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 2 are a HOLD (7.14%), 26 are a BUY (92.86%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Mar-2020

$33

$12.1 (57.89%)

$30

11 days ago
(11-Nov-2026)

4/14 (28.57%)

$7.19 (27.86%)

116

Buy Since 05-Jan-2022

$51

$30.1 (144.02%)

$55

17 days ago
(05-Nov-2026)

0/5 (0%)

$25.13 (97.14%)

Buy Since 23-Jul-2024

$80

$59.1 (282.78%)

$80

1 months 7 days ago
(15-Oct-2026)

0/22 (0%)

$55.27 (223.49%)

Buy Since 28-Mar-2025

$47

$26.1 (124.88%)

$47

4 months 14 days ago
(08-Jul-2026)

0/3 (0%)

$10.12 (27.44%)

Buy Since 11-Mar-2025

$39

$18.1 (86.60%)

$40

6 months 9 days ago
(13-May-2026)

7/10 (70%)

$7.15 (22.45%)

348

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics) average time for price targets to be met?

On average it took 79 days for the stock forecasts to be reached, with an average price target met ratio of 39.42%.

Which analyst most recently updated their price target on BEAM (Beam Therapeutics)?

David Nierengarten

Which analyst has the most public recommendations on BEAM (Beam Therapeutics)?

David Nierengarten works at WEDBUSH and has 4 price targets and 4 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics)?

Patrick Trucchio with the highest potential upside of $59.1

Which analyst is the currently most reserved on BEAM (Beam Therapeutics)?

Rick Bienkowski with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?